Delivery Order SPE2DR25D6028-SPE2DR26FARFC
- Not listed
- The Defense Logistics Agency awarded a $5,330.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable medication used to treat autoimmune conditions. The contract, with an ultimate completion date of September 10, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was made on a competitive basis with no...
- The Defense Logistics Agency awarded a $1,510.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL pharmaceutical supplies on September 3, 2025, with completion targeted for September 4, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $32,329.46 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical supplies. This firm fixed-price contract, executed on September 24, 2025, with an ultimate completion date of September 25, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and will be performed at the...
- The Defense Logistics Agency awarded a $12,288.46 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical supplies. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency awarded a $36,425.77 delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40mg/4ml (2 units) under a firm fixed price contract. This delivery order, issued on October 27, 2025, with an ultimate completion date of November 24, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been selected to fulfill this medical supply...
- The Defense Logistics Agency has awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40 mg/0.8 mL units. This competitively awarded, firm fixed price contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. HUMIRA is a widely used biologic medication for treating autoimmune conditions including rheumatoid arthritis,...
- The Defense Logistics Agency awarded a delivery order valued at $2,259.23 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on November 13, 2025, with a completion date of November 14, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The product will be delivered from the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat inflammatory conditions. This firm fixed-price delivery order, valued at $1,575.72, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The award was made on a...
- The Defense Logistics Agency awarded a delivery order valued at $1,227.99 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on November 7, 2025, with completion scheduled for November 10, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. HUMIRA is a biologic immunosuppressant medication used to treat various inflammatory and autoimmune conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mls, a pharmaceutical product for treating autoimmune conditions. The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, utilizes firm fixed pricing with no set-aside designation, indicating the award was made through open competition. Performance will be executed at AmerisourceBergen's corporate office location in...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARFCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $35,031.32 to AmerisourceBergen Drug Corp for HUMIRA Pen 40mg/4ml pharmaceutical supplies on November 3, 2025, with completion by November 4, 2025. This firm fixed-price delivery order, issued without a set-aside designation, will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a competitive procurement under the company's broader pharmaceutical supply contract vehicle with the federal government. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving the Defense Health Agency, military healthcare systems, and other federal medical supply chains. The company routinely fulfills federal procurement requirements for a comprehensive range of pharmaceutical products and medical supplies, including brand-name medications, generic drugs, vaccines, and specialized medical devices across multiple therapeutic domains. This particular delivery order for HUMIRA, a brand-name immunosuppressant medication commonly used for rheumatoid arthritis and other autoimmune conditions, demonstrates the vendor's role in supplying critical pharmaceutical products to support military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.0k | 11/3/25 |